Q3 FY2026 · ended Sep 30, 2026 · Revenue $67.97M, +11.3% YoY · Filed Nov 5, 2026
Lemaitre Vascular, Inc. (LMAT) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In Q3 of fiscal 2026, the quarter ended Sep 30, 2026, it reported revenue of $68.0 million and net income of $15.0 million. Free cash flow was $19.7 million. As of Sep 30, 2026 it held $389.7 million in cash and investments and $19.5 million in total debt.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- LMAT (Nasdaq)
- Fiscal year ends
- December 31
- Headquarters
- Burlington, MA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1158895
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q3 FY2026 Sep 30, 2026 |
Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $68.0M | $70.4M | $66.6M | $64.5M | $61.0M |
| Operating income | $17.7M | $20.4M | $17.8M | $18.8M | $20.3M |
| Net income | $15.0M | $17.1M | $15.7M | $15.6M | $17.4M |
| Diluted EPS | $0.65 | $0.74 | $0.68 | $0.68 | $0.75 |
| Operating cash flow | $22.0M | $16.0M | $15.1M | $23.2M | $28.8M |
| Free cash flow | $19.7M | $13.7M | $12.3M | $21.4M | $26.5M |
| Total assets | $656.0M | $640.5M | $629.5M | $615.7M | $598.1M |
| Total liabilities | $223.9M | $220.2M | $222.9M | $222.2M | $219.1M |
| Stockholders' equity | $432.1M | $420.3M | $406.6M | $393.5M | $378.9M |
| Cash and investments | $389.7M | $376.2M | $367.2M | $359.1M | $343.1M |
| Total debt | $19.5M | $21.2M | $20.9M | $16.9M | $17.2M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 5, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 4, 2026 | Nov 4, 2026 |
| 8-K |
Current report
Officer or director change
|
Oct 15, 2026 | Oct 9, 2026 |
| 10-Q | Quarterly report | Aug 5, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 4, 2026 | Aug 4, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 5, 2026 | Jun 2, 2026 |
All 1002 Lemaitre Vascular, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.